TransMedics Group Statistics
NASDAQ: TMDXHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
85.25-8.77 (-9.33%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TransMedics Group by the numbers
TransMedics Group has a market capitalization of $2.96 billion based on 34.73M shares outstanding. Its trailing P/E ratio is 23.2, above the 4-company peer median of 18.0, and its forward P/E is 34.3. The stock trades 5.4% above its 50-day average and 5.9% below its 200-day average.
Average daily trading volume is 930.13K shares, or about $79.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TMDX valuation vs. peer median
| Metric | TMDX | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.96B | $889.19M | +233% |
| P/E (TTM) | 23.2 | 18.0 | +29% |
| Forward P/E | 34.3 | 19.2 | +79% |
| Avg. volume | 930.13K | 408.47K | +128% |
Peer median across 8 companies: AXGN, CNMD, CBLL, LIVN, INMD, CV, ELMD, FOCL.
Valuation
- Market cap
- $2.96B
- P/E (TTM)
- 23.23
- Forward P/E
- 34.31
- Price / sales (latest FY)
- 4.89
- EPS (TTM)
- $3.67
- Shares outstanding
- 34.73M
Price and trading
- Previous close
- 94.02
- Open
- 91.62
- Day range
- 83.89 – 91.62
- 52-week range
- 60.11 – 156.00
- 52-week change
- -34.89%
- Beta
- —
- Volume
- 1.59M
- Average volume
- 930.13K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 2.96B
- Pe
- 23.23
- Forward Pe
- 34.31
- Eps
- 3.67
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 156.00
- Week52 Low
- 60.11
- Avg Volume
- 930.13K
- Shares Outstanding
- 34.73M
- Ma50
- 80.88
- Ma200
- 90.62
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -45.35%
- Pct From52w Low
- 41.84%